Details of the Drug

General Information of Drug (ID: DMOUEY7)

• Drug Name: Mesenchymal stem cells
• Synonyms: MSCs

Indication

Disease Entry	ICD 11	Status	REF
Epidermolysis bullosa	EC3Z	Approved	[1]
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 2	[2]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: D01CAH
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (FDA ORPHAN DRUG) 427014
• [2] ClinicalTrials.gov (NCT04288102) Treatment With Mesenchymal Stem Cells for Severe Corona Virus Disease 2019(COVID-19). U.S. National Institutes of Health.